• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Niox Group PLC (NIOX)

ORD 0.08P
Sell: 56.60p|Buy: 57.20p|Change: 0.80 (1.42%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

NIOX Group PLC is engaged in improving the diagnosis, monitoring and management of both asthma and COPD by providing greater patient access to FeNO testing. The company is engaged in the design, development, and commercialization of medical devices for the measurement of FeNO, a precise biomarker for type 2 inflammation which is present in asthma and COPD. Its device, NIOX VERO, is increasingly recognised by healthcare professionals as an important tool to improve the diagnosis, monitoring and management of asthma and COPD. It operates in single segment of NIOX relates to the portfolio of products used to improve asthma diagnosis, monitoring and management by measuring fractional exhaled nitric oxide (FeNO).

Address

Magdalen Centre, Robert Robinson Avenue
Northbrook House, Oxford Science Park
Oxford
GBR
OX4 4GA

Telephone

+44 1865405560

Website

https://www.niox.com

Sector 

Healthcare

Forecast key dates

NameKey Date
NIOX Group PLC Fourth Quarter Earnings Results for 20262027-03-24T00:00:00
NIOX Group PLC Annual Report for 20262027-03-24T00:00:00
NIOX Group PLC Second Quarter Earnings Results for 20262026-09-30T00:00:00
NIOX Group PLC Annual General Meeting for 20262026-05-21T10:00:00

Previous key dates

NameKey Date
NIOX Group PLC Fourth Quarter Earnings Results for 20252026-03-24T00:00:00
NIOX Group PLC Annual Report for 20252026-03-24T00:00:00
NIOX Group PLC Second Quarter Earnings Results for 20252025-09-30T00:00:00
NIOX Group PLC Annual General Meeting for 20252025-05-14T11:00:00
NIOX Group PLC Fourth Quarter Earnings Results for 20242025-04-01T00:00:00
NIOX Group PLC Annual Report for 20242025-04-01T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.